Hot penny stocks... don't get burned
   

Cash Flow for Acadia Pharmaceuticals, Inc (ACAD)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
Cash Flow for ACADIA Pharmaceuticals Inc.  (ACAD) 
$ 2.82      0.42 (+17.50%) Volume: 203.87 k 4:00 PM EDT Sep 5, 2008
After Hours:  $ 2.81   -0.01 (-0.35%) Volume: 400 4:00 PM EDT Sep 5, 2008
Statement: View:
Cash Flow in Thousands of Dollars
12/2007 12/2006 12/2005 12/2004 12/2003
Net Income (56,390) (45,048) (34,135) (25,917) (14,093)
Depreciation & Amortization 1,065 852 1,026 1,306 1,344
Deferred Income Taxes - - - - -
Operating Losses (155) (176) 1,459 2,363 1,392
Extraordinary Losses - - - - -
Decrease in Receivables - - - - -
Decrease in Inventories - - - - -
Decrease in Other Current Assets - - (98) 107 82
Increase in Payables (845) 1,314 (80) 578 320
Increase in Other Current Liabilities (516) (2,588) 14,278 1,472 1,316
Decrease in Other Working Capital (295) (227) - - -
Other Non-Cash Items 4,295 3,378 - - -
Net Cash from Continuing Operations (54,926) (41,418) (20,263) (20,693) (9,816)
Net Cash from Discontinued Operations - - - - -
Cash from Operating Activities (54,926) (41,418) (20,263) (20,693) (9,816)
Sale of Property, Plant, Equipment - - - - -
Sale of Short Term Investments 180,745 83,166 48,893 29,853 24,150
Purchase of Property, Plant, Equipment (416) (2,026) (1,022) (585) (1,777)
Acquisitions - - - - -
Purchase of Short Term Investments (222,231) (116,596) (54,523) (36,646) (37,064)
Other Investment Changes, Net - 12,520 - - -
Cash from Investing Activities (41,902) (22,936) (6,651) (7,379) (14,691)
Issuance of Debt 754 1,626 782 1,952 1,452
Issuance of Capital Stock 98,599 69,403 41,670 31,501 28,024
Repayment of Debt (1,133) (1,033) (1,562) (3,347) (3,072)
Repurchase of Capital Stock - - - - -
Payment of Cash Dividends - - - - -
Other Financing Charges, Net - - (12,520) - -
Cash from Financing Activities 98,220 69,996 28,370 30,106 26,404
Effect of Exchange Rate Changes 115 42 38 (41) (42)
Net Change in Cash 1,507 5,684 1,494 1,994 1,854
Cash at Beginning of Year 15,480 9,796 8,302 6,308 4,454
Cash at End of Period 16,987 15,480 9,796 8,302 6,308

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, financials by Hemscott.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for ACAD stock. Download ACAD report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download ACAD report
  
Example preview: Research report for Acadia Pharmaceuticals, Inc (ACAD) Research report for Acadia Pharmaceuticals, Inc (ACAD) Research report for Acadia Pharmaceuticals, Inc (ACAD) Research report for Acadia Pharmaceuticals, Inc (ACAD)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   

SPKL shot up 21%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Acadia Pharmaceuticals, Inc